COVID-19 and Its Sequelae Masquerading as Gastrointestinal Ailments: A Report of Gastroesophageal Reflux Disease (GERD) and Review of Recent Cases.
| Autor: | Shweikeh F; Internal Medicine, Cleveland Clinic Akron General, Akron, USA., Hong G; Internal Medicine, University Hospitals Cleveland Medical Center, Cleveland, USA., Rabeeah S; Internal Medicine, The University of Toledo Medical Center, Toledo, USA., Shabir U; Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, USA., Sofi A; Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2024 Apr 04; Vol. 16 (4), pp. e57617. Date of Electronic Publication: 2024 Apr 04 (Print Publication: 2024). |
| DOI: | 10.7759/cureus.57617 |
| Abstrakt: | Coronavirus disease 2019 (COVID-19) predominantly causes respiratory symptoms. However, a rare segment of patients recovering from COVID-19 may develop gastrointestinal (GI) symptoms. We describe a case of a female who presented with symptoms suggestive of refractory gastroesophageal reflux disease (GERD) for 18 months following COVID-19 infection. Her symptoms included epigastric and chest pain, coughing, and vomiting. Upper endoscopy and 24-hour pH monitoring were negative. Following hospital admission due to worsening symptoms, she was diagnosed with chronic pulmonary embolism (PE) presumed to be related to COVID-19. Her reflux symptoms resolved within two days of the initiation of anticoagulation. Our findings suggest that chronic PE should be considered in patients presenting with GERD refractory to treatment following COVID-19 infection. Generally, as COVID-19 and its sequelae may masquerade as GI conditions, they should be on the differential diagnosis, especially in the post-pandemic era when routine testing has significantly declined. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2024, Shweikeh et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|